A universal tumor treatment for a universal cancer marker By Dr Ananya Mandal.

A universal tumor treatment for a universal cancer marker By Dr Ananya Mandal, MD A latest study shows that a hormone receptor normally confined to the reproductive organs is found in malignant tumors in many areas of the body. Experts from the Mt http://www.synmcg.com/ . Sinai College of Medicine in New York City explained that may mean a fresh target for the early diagnosis and treatment of malignancy. The scholarly study was published in the most recent issue of THE BRAND NEW England Journal of Medication. They studied tumor tissue samples from 1,336 men and women with 11 common cancers, including prostate, breasts, colon, pancreatic, lung, liver and ovarian and discovered the presence of the follicle-stimulating hormone receptor in the bloodstream vessel cells of the tumors.

Data collected prospectively means information about dietary and environmental exposures had been collected ahead of diagnosis with pancreatic tumor. Researchers identified 2,187 individuals diagnosed with pancreatic cancer during the study. ‘This is among the largest research ever to check out dietary factors in relation to pancreatic cancers risk,’ says lead writer Jeanine M. Genkinger, Ph.D., an assistant professor at Georgetown University’s Lombardi Comprehensive Malignancy Center. If individuals consumed 30 or even more grams of alcohol per day , compared with no alcohol each day, their threat of pancreatic cancer was increased slightly, researchers said. A drink is defined as 12 ounces of beer, four ounces of wines, or 1.5 ounces of 80-proof distilled liquor.